Immunogenicity of the histidine-to-tyrosine staphylococcal enterotoxin B mutant protein in C3H/HeJ mice

Toxicon

Volumn 43, Issue 4, 2004, Pages 433-438

  Savransky, Vladimir ^a   Pinelis, Dmitriy ^b   Korolev, Sergey ^a   Ionin, Boris ^a   Fegeding, Konstantin ^c  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b GOOD SAMARITAN HOSPITAL   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Immunity; Superantigen; Toxic shock; Vaccine

Indexed keywords

DACTINOMYCIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; MUTANT PROTEIN; STAPHYLOCOCCUS ENTEROTOXIN B; STAPHYLOCOCCUS ENTEROTOXIN B VACCINE; STAPHYLOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; FOOD POISONING; IMMUNOGENICITY; INTOXICATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SEPTIC SHOCK; TOXICITY;

ANIMALS; DACTINOMYCIN; ENTEROTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; MICE; MICE, INBRED C3H; MUTATION; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; TYROSINE;

ANIMALIA; POSIBACTERIA; STAPHYLOCOCCUS;

EID: 1642503691     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2004.02.013     Document Type: Article

References (25)

1. Bergdoll M.S. Immunization of monkeys with enterotoxoid B. J. Infect. Dis. 116:1966;191-196.
2. Bonin O. Requirements on the production and testing of sera and vaccines. Fortschr. Med. 95:1977;1541-1548.
3. Chen J.Y., Qiao Y., Komisar J.L., Baze W.B., Hsu I.C., Tseng J. Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D. Infect. Immun. 62:1994;4626-4631.
4. Coffman J.D., Zhu J., Roach J.M., Bavari S., Ulrich R.G., Giardina S.L. Production and purification of a recombinant staphylococcal enterotoxin B vaccine candidate expressed in Escherichia coli. Protein Exp. Purif. 24:2002;302-312.
5. Collins L.V., Eriksson K., Ulrich R.G., Tarkowski A. Mucosal tolerance to a bacterial superantigen indicates a novel pathway to prevent toxic shock. Infect. Immun. 70:2002;2282-2287.
6. Desai M.P., Hilfinger J.M., Amidon G.L., Levy R.J., Labhasetwar V. Immune response with biodegradable nanospheres and alum: studies in rabbits using staphylococcal enterotoxin B-toxoid. J. Microencapsul. 17:2000;215-225.
7. Gampfer J., Thon V., Gulle H., Wolf H.M., Eibl M.M. Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome. Vaccine. 20:2002;1354-1364.
8. Jett M., Ionin B., Das R., Neill R. The staphylococcal enterotoxins. Sussman M. Molecular Medical Microbiology. 2001;Academic Press, London.
9. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature. 348:1991;245-248.
10. Korolev S., Pinelis D., Savransky V., Komisar J., Vogel P., Fegeding K. Toxicity of the staphylococcal enterotoxin B mutants with histidine-to-tyrosine substitutions. Toxicology. 187:(2/3):2003;229-238.
11. Kuschnaroff L.M., Valckx D., Goebels J., Rutgeerts O., Heremans H., Froyent G., Waer M. Effect of treatments with cyclosporin A and anti-interferon-gamma antibodies on the mechanisms of immune tolerance in staphylococcal enterotoxin B primed mice. Scand. J. Immunol. 46:1997;459-468.
12. Lee J.S., Dyas B.K., Nystrom S.S., Lind C.M., Smith J.F., Ulrich R.G. Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon. J. Infect. Dis. 185:2002;1192-1196.
13. McCormick J.K., Yarwood J.M., Schlievert P.M. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 55:2001;77-104.
14. Nilsson I.M., Verdrengh M., Ulrich R.G., Bavari S., Tarkowski A. Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity. J. Infect. Dis. 180:1999;1370-1373.
15. Robertson J.S., Cichutek K. European Union guidance on the quality, safety and efficacy of DNA vaccines and regulatory requirements. Dev. Biol. (Basel). 104:2000;53-56.
16. Sabapathy T.K., Hwang L.A., Hui K.M. Differential effect of staphylococcal enterotoxin B upon the induction of tolerance on peripheral CD4+Vβ 8+ and CD8+Vβ 8+ T cells. Cell. Immunol. 158:1994;83-95.
17. Savransky V., Rostapshov V., Pinelis D., Polotsky Y., Komisar J., Fegeding K. Murine lethal toxic shock caused by intranasal administration of staphylococcal enterotoxin B. Toxicol. Pathol. 31:(4):2003;373-378.
18. Shupp J.W., Jett M., Pontzer C.H. Identification of a transcytosis epitope on staphylococcal enterotoxins. Infect. Immun. 70:2002;2178-2186.
19. Silverman S.J., Espeseth D.A., Schantz E.J. Effect of formaldehyde on the immunochemical and biological activity of staphylococcal enterotoxin B. J. Bacteriol. 98:1969;437-442.
20. Stiles B.G., Garza A.R., Ulrich R.G., Boles J.W. Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model. Infect. Immun. 69:2001;2031-2036.
21. Swaminathan S., Furey W., Pletcher J., Sax M. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature. 359:1992;801-806.
22. Tseng J., Komisar J.L., Trout R.N., Hunt R.E., Chen J.Y., Johnson A.J., Pitt L., Ruble D.L. Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres. Infect. Immun. 63:1995;2880-2885.
23. Valle J., Vadillo S., Piriz S., Gomez-Lucia E. Detection of antibodies to Staphylococcal enterotoxins in the serum and milk of healthy goats. FEMS Microbiol. Immunol. 3:1991;53-58.
24. Williams O., Aroeira L.S., Mengel J. T cell-dependent antibody response to staphylococcal enterotoxin B. Scand. J. Immunol. 42:1995;305-310.
25. Woody M.A., Krakauer T., Stiles B.G. Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model. Vaccine. 15:1997;133-139.